Harvard Bioscience, Inc.
NASDAQ: HBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- John D. Duke
- Employees
- 331
- Headquarters
- Holliston, United States
- IPO year
- 2001
- Market cap
- $27.4M
- Website
- https://www.harvardbioscience.com
Loading HBIO…
Loading profile data…Frequently asked questions about HBIO
What does Harvard Bioscience, Inc. (HBIO) do?
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and elect...
Where does HBIO trade?
Harvard Bioscience, Inc. (HBIO) trades on the NASDAQ.
What sector is HBIO in?
Harvard Bioscience, Inc. (HBIO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Harvard Bioscience, Inc.?
John D. Duke is the chief executive officer of Harvard Bioscience, Inc. (HBIO).
Where is Harvard Bioscience, Inc. headquartered?
Harvard Bioscience, Inc. is headquartered in United States.
Does HBIO pay a dividend?
Harvard Bioscience, Inc. (HBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HBIO go public?
Harvard Bioscience, Inc. (HBIO) completed its initial public offering in 2001.